Abstract
IDARS is an acronym for the International Drug Abuse Research Society. Apart from our scientific and educational purposes, we communicate information to the general and scientific community about substance abuse and addiction science and treatment potential. Members of IDARS are research scientists and clinicians from around the world, with scheduled meetings across the globe. IDARS is developing a vibrant and exciting international mechanism not only for scientific interactions in the domain of addiction between countries but also ultimately as a resource for informing public policy across nations. Nonetheless, a lot more research needs to be done to better understand the neurobiological basis of drug addiction – A challenge for IDARS scientists.
Keywords: International Drug Abuse Research Society, IDARS, addiction, alcohol, marijuana, psychostimulants, Addiciton, CNR1, CNR2, Cannabinoids Receptors (CBRs), Obesity, NMDAR
Current Neuropharmacology
Title: Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists
Volume: 9 Issue: 1
Author(s): S. F. Ali, E. S. Onaivi, P. R. Dodd, J. L. Cadet, S. Schenk, M. J. Kuhar and G. F. Koob
Affiliation:
Keywords: International Drug Abuse Research Society, IDARS, addiction, alcohol, marijuana, psychostimulants, Addiciton, CNR1, CNR2, Cannabinoids Receptors (CBRs), Obesity, NMDAR
Abstract: IDARS is an acronym for the International Drug Abuse Research Society. Apart from our scientific and educational purposes, we communicate information to the general and scientific community about substance abuse and addiction science and treatment potential. Members of IDARS are research scientists and clinicians from around the world, with scheduled meetings across the globe. IDARS is developing a vibrant and exciting international mechanism not only for scientific interactions in the domain of addiction between countries but also ultimately as a resource for informing public policy across nations. Nonetheless, a lot more research needs to be done to better understand the neurobiological basis of drug addiction – A challenge for IDARS scientists.
Export Options
About this article
Cite this article as:
F. Ali S., S. Onaivi E., R. Dodd P., L. Cadet J., Schenk S., J. Kuhar M. and F. Koob G., Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists, Current Neuropharmacology 2011; 9 (1) . https://dx.doi.org/10.2174/157015911795017245
DOI https://dx.doi.org/10.2174/157015911795017245 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current and Experimental Pharmacological Approaches in Neonatal Hypoxic- Ischemic Encephalopathy
Current Pharmaceutical Design Neuroprotective Effects of Ellagic Acid in Alzheimer's Disease: Focus on Underlying Molecular Mechanisms of Therapeutic Potential
Current Pharmaceutical Design Bedside Lung Ultrasound in the Care of the Critically Ill
Current Respiratory Medicine Reviews Amine Oxidase Inhibitors and Development of Neuroprotective Drugs
Current Neuropharmacology Cell-and Gene-based Therapeutic Approaches for Neurological Deficits in Mucopolysaccharidoses
Current Pharmaceutical Biotechnology Sirtuin Modulators: Mechanisms and Potential Clinical Implications
Current Medicinal Chemistry Neuropathic Pain and Lung Delivery of Nanoparticulate Drugs: An Emerging Novel Therapeutic Strategy
CNS & Neurological Disorders - Drug Targets Personalized Medicine Using Cutting Edge Technologies for Genetic Epilepsies
Current Neuropharmacology Prion Protein Functions and Dysfunction in Prion Diseases
Current Medicinal Chemistry Potential for Stem Cells Therapy in Alzheimer’s Disease: Do Neurotrophic Factors Play Critical Role?
Current Alzheimer Research Scutellarin Attenuates Microglia-Mediated Neuroinflammation and Promotes Astrogliosis in Cerebral Ischemia - A Therapeutic Consideration
Current Medicinal Chemistry The Antidiabetic PPARγ Ligands: An Update on Compounds in Development
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Insulin-Like Growth Factor-1 and its Derivatives: Potential Pharmaceutical Application for Treating Neurological Conditions
Recent Patents on CNS Drug Discovery (Discontinued) Exosomes and the Emerging Field of Exosome-Based Gene Therapy
Current Gene Therapy Medicinal Chemistry Insights into Novel HDAC Inhibitors: An Updated Patent Review (2012-2016)
Recent Patents on Anti-Cancer Drug Discovery Cell Elimination as a Strategy for Repair in Acute Spinal Cord Injury
Current Pharmaceutical Design Possibility of Non-Immunosuppressive Immunophilin Ligands as Potential Therapeutic Agents for Parkinsons Disease
Current Pharmaceutical Design Remediation of Cellular Hypoxic Damage by Pharmacological Agents
Current Pharmaceutical Design Calpain Inhibition: A Therapeutic Strategy Targeting Multiple Disease States
Current Pharmaceutical Design Reviewing the Role of Resveratrol as a Natural Modulator of Microglial Activities
Current Pharmaceutical Design